Monoclonal antibodies cut risk of dying from COVID-19—but only in some patients
Regeneron cocktail reduces mortality by 20% in those who don’t produce antibodies themselves, RECOVERY trial shows
Related Articles
Watch a marlin flash bright stripes before a deadly strike
Rapid color changes may prevent these predators from impaling one another during group attacks
In a bold bid to avoid open-access fees, Gates foundation says grantees must post preprints
Foundation’s move leaves questions about how to fund peer review
Simple electrical circuit learns on its own—with no help from a computer
System sidesteps computing bottleneck in tuning artificial intelligence algorithms
Researchers need ‘open’ bibliographic databases, new declaration says
Major platforms such as the Web of Science, widely used to generate metrics and evaluate researchers, are proprietary
Giant planets ran amok soon after Solar System’s birth
Meteorites suggest cataclysmic “instability” occurred around the time of the Moon’s formation
Controversial wolf killing appears to help caribou, but concerns persist
Some worry the findings will stall efforts to halt logging—the root cause of declining caribou populations
News at a glance: Global coral bleaching, preventing ship strikes on whales, and detecting prostate cancer
The latest in science and policy
Bacteria found in mosquito guts could help scientists fight dengue, Zika
Newly identified microbe disables the viruses before they can infect the insects, potentially reducing disease transmission in people
Daring ‘James Bond’ mission to drill Antarctic ices cores could reveal future of sea level rise
To understand vulnerable glaciers, climate scientists extract ice from continent’s remote and stormy coast
Charred bones are signs of Maya ritual to erase past rulers
Twelve-hundred-year-old burnt remains in Guatemala reflect political turmoil that led to the eventual collapse of empire